Protein western array analysis in human pituitary tumours: Insights and limitations

Endocrine-Related Cancer

Volumn 15, Issue 4, 2008, Pages 1099-1114

  Ribeiro Oliveira Jr , Antônio ^a,b   Franchi, Giulia ^a,c   Kola, Blerina ^a   Dalino, Paolo ^a,d   Pinheiro, Sérgio Veloso Brant ^b   Salahuddin, Nabila ^a   Musat, Madalina ^a   Góth, Miklós I ^e   Czirják, Sándor ^f   Hanzély, Zoltán ^f   da Silva, Deivid Augusto ^b   Paulino Jr , Eduardo ^b   Grossman, Ashley B ^a   Korbonits, Márta ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

^e NATIONAL MEDICAL CENTER   (Hungary)

^f NATIONAL INSTITUTE OF NEUROSURGERY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 3; ARGININOSUCCINATE SYNTHASE; BINDING PROTEIN; BRADYKININ B2 RECEPTOR; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALDESMON; CHOLINERGIC RECEPTOR; CORTICOTROPIN; DNA BINDING PROTEIN; EPOXIDE HYDROLASE; ERYTHROCYTE BAND 4.9 PROTEIN; GROWTH HORMONE; HEAT SHOCK PROTEIN 110; LAMIN A; LAMIN C; LIPOCORTIN 1; LIPOCORTIN 2; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MYOCYTE ENHANCER FACTOR 2; PROLACTIN; PROTEIN BAX; PROTEIN KINASE P60; RAB PROTEIN; RETINOL BINDING PROTEIN; RIBOSOME PROTEIN; RNA BINDING PROTEIN; X LINKED INHIBITOR OF APOPTOSIS;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; FROZEN SECTION; GENE OVEREXPRESSION; HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; PATHOGENESIS; PROLACTINOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEOMICS; TRANSSPHENOIDAL SURGERY; WESTERN BLOTTING;

ADENOMA; BLOTTING, WESTERN; HUMANS; NEOPLASM PROTEINS; PITUITARY GLAND; PITUITARY NEOPLASMS; PROTEIN ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 58249118899     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-08-0003     Document Type: Article

References (35)

1. Kaltsas GA, Kola B, Borboli N, Morris DG, Gueorguiev M, Swords FM, Czirjak S, Kirschner LS, Stratakis CA, Korbonits M et al. 2002 Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours. Clinical Endocrinology 57 443-448.
2. Kaltsas GA, Nomikos P, Kontogeorgos G, Buchfelder M & Grossman AB 2005 Clinical review: diagnosis and management of pituitary carcinomas. Journal of Clinical Endocrinology and Metabolism 90 3089-3099.
3. Kim SO, Avraham S, Jiang SX, Zagozdzon R, Fu YG & Avraham HK 2004 Differential expression of Csk homologous kinase (CHK) in normal brain and brain tumors. Cancer 101 1018-1027.
4. Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA & Stratakis CA 2000 Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Human Molecular Genetics 9 3037-3046.
5. Kuan SI, Judd AM, Jarvis WD, Login IS & MacLeod RM 1990 Physiological and biochemical effects of bradykinin and lys-bradykinin in pituitary cells. Molecular and Cellular Endocrinology 72 239-246.
6. Lee SU, Kim BT, Min YK & Kim SH 2006 Protein profiling and transcript expression levels of heat shock proteins in l7beta-estradiol-treated human MCF-7 breast cancer cells. Cell Biology International 30 983-991.
7. Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S, Chahal HS, Igreja SC, Jordan S, Rowe J et al. 2008 The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 93 2390-2401.
8. Lidhar K, Korbonits M, Jordan S, Khalimova Z, Kaltsas G, Lu X, Clayton RN, Jenkins PJ, Monson JP, Besser GM et al. 1999 Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. Journal of Clinical Endocrinology and Metabolism 84 3823-3 830.
9. Lloyd RV, Ruebel KH, Zhang SY & Jin L 2002 Pituitary hyperplasia in glycoprotein hormone alpha subunit-,p18(INK4C)-, and p27(kip-1)-null mice - analysis of proteins influencing p27(kip-1) ubiquitin degradation. American Journal of Pathology 160 1171-1179.
10. Ma JX, Finley RL, Waisman DM & Sloane BF 2000 Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. Journal of Biological Chemistry 275 12806-12812.
11. Martin GS 2006 Fly Src: the Yin and Yang of tumor invasion and tumor suppression. Cancer Cell 9 4-6.
12. Melle C, Bogumil R, Ernst G, Schimmel B, Bleul A & von Eggeling F 2006 Detection and identification of heat shock protein 10 as a biomarker in colorectal cancer by protein profiling. Proteomics 6 2600-2608.
13. Moreno CS, Evans CO, Zhan X, Okor M, Desiderio DM & Oyesiku NM 2005 Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. Cancer Research 65 10214-10222.
14. Morris DG, Musat M, Cziják S, Hanzély Z, Lillington D, Korbonits M & Grossman AB 2005 Differential gene expression in pituitary adenomas by oligonucleotide array analysis. European Journal of Endocrinology 153 1-10.
15. Mulla A, Christian HC, Solito E, Mendoza N, Morris JF & Buckingham JC 2004 Expression, subcellular localization and phosphorylation status of annexins 1 and 5 in human pituitary adenomas and a growth hormone-secreting carcinoma. Clinical Endocrinology 60 107-119.
16. Musat M, Korbonits M, Kola B, Borboli N, Hanson MR, Nanzer AM, Grigson J, Jordan S, Morris DG, Gueorguiev M et al. 2005 Enhanced protein kinase B/Akt signalling in pituitary turnouts. Endocrine-Related Cancer 12 423-433.
17. Okui M, Ito F, Ogita K, Kuramoto N, Kudoh J, Shimizu N & Ide T 2000 Expression of APG-2 protein, a member of the heat shock protein 110 family, in developing rat brain. Neurochemistry International 36 35-43.
18. Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Hofler H, Fend F, Graw J & Atkinson MJ 2006 Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. PNAS 103 15558-15563.
19. Phelan ML & Nock S 2003 Generation of bioreagents for protein chips. Proteomics 3 2123-2134.
20. Satta MA, Korbonits M, Jacobs RA, Bolden-Dwinfour DA, Kaltsas GA, Vangeli V, Adams E, Fahlbusch R & Grossman AB 1999 Expression of menin gene mRNA in pituitary tumours. European Journal of Endocrinology 140 358-361.
21. Senda T, Okabe T, Matsuda M & Fujita H 1994 Quick-freeze, deep-etch visualization of exocytosis in anterior-pituitary secretory-cells - localization and possible roles of actin and annexin-Ii. Cell and Tissue Research 277 51-60.
22. Senzer N, Shen YQ, Hill C & Nemunaitis J 2005 Individualised cancer therapeutics: dream or reality? Expert Opinion on Therapeutic Targets 9 1189-1201.
23. Sharif NA, Hunter JC, Hill RG & Hughes J 1988 Bradykinin-induced accumulation of [3H]inositol-1-phosphate in human embryonic pituitary tumour cells by activation of a B2-receptor. Neuroscience Letters 86 279-283.
24. Stewart JM, Gera L, Chan DC, Whalley ET, Hanson WL & Zuzack JS 1997 Long-acting, orally-active bradykinin antagonists for a wide range of applications. Immunopharmacology 36 167-172.
25. Traverso V, Christian HC, Morris JF & Buckingham JC 1999 Lipocortin 1 (annexin 1): a candidate paracrine agent localized in pituitary folliculo-stellate cells. Endocrinology 140 4311-4319.
26. Turgeon JL, Cooper RH & Waring DW 1991 Membrane-specific association of annexin-I and annexin-Ii in anterior-pituitary-cells. Endocrinology 128 96-102.
27. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R et al. 2006 Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312 1228-1230.
28. Wang XY, Kazim L, Repasky EA & Subjeck JR 2001 Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity. Journal of Immunology 166 490-497.
29. Xin W, Rhodes DR, Ingold C, Chinnaiyan AM & Rubin MA 2003 Dysregulation of the annexin family protein family is associated with prostate cancer progression. American Journal of Pathology 162 255-261.
30. Yousef GM & Diamandis EP 2003 An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers. Clinical Biochemistry 36 443-452.
31. Yousef GM, Kishi T & Diamandis EP 2003 Role of kallikrein enzymes in the central nervous system. Clinica Chimica Acta 329 1-8.
32. Zhan X & Desiderio DM 2003 A reference map of a human pituitary adenoma proteome. Proteomics 3 699-713.
33. Zhan X, Evans CO, Oyesiku NM & Desiderio DM 2003 Proteomics and transcriptomics analyses of secretagogin down-regulation in human non-functional pituitary adenomas. Pituitary 6 189-202.
34. Zhao Y, Giorgianni F, Desiderio DM, Fang B & Beranova-Giorgianni S 2005a Toward a global analysis of the human pituitary proteome by multiple gel-based technology. Analytical Chemistry 77 5324-5331.
35. Zhao Y, Xue Y, Liu Y, Fu W, Jiang N, An P, Wang P, Yang Z & Wang Y 2005b Study of correlation between expression of bradykinin B2 receptor and pathological grade in human gliomas. British Journal of Neurosurgery 19 322-326.